Cambridge, MA, United States of America

Scott Delach

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 5.5

ph-index = 2

Forward Citations = 14(Granted Patents)


Location History:

  • Waltham, MA (US) (2017)
  • Cambridge, MA (US) (2018)

Company Filing History:


Years Active: 2017-2018

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Scott Delach

Introduction

Scott Delach is a noteworthy inventor based in Cambridge, Massachusetts, recognized for his significant contributions to medical research and innovation. With a total of three patents to his name, Delach is making strides in the fields of oncology and genetic research through his work at Novartis AG.

Latest Patents

Delach's latest patents address pressing medical issues, particularly in relation to the androgen receptor (AR) and its role in various diseases. One of his prominent inventions involves compositions and methods for diagnosing, prognosing, and treating AR-related conditions, including prostate cancer and breast cancer. Notably, he identified a clinically relevant mutation at position 877 of the androgen receptor, which may allow for predicting drug sensitivity and tailoring therapeutic regimens based on the mutation's presence or absence. Additionally, his research highlights a double mutation at positions 742 and 878 that aids in patient stratification. Another significant patent presented by Delach includes a pharmaceutical combination with binimetinib, aimed at enhancing treatment efficacy in diseases such as cancer by combining a CDK4/6 inhibitor and a MEK inhibitor.

Career Highlights

Delach's career is characterized by his dedication to advancing cancer treatment and enhancing patient outcomes through innovative research. His role at Novartis AG positions him at the forefront of pharmaceutical development, and his inventions corroborate his expertise in the field of medical pharmacology.

Collaborations

Throughout his career, Delach has collaborated with notable coworkers such as Giordano Caponigro and Sunkyu Kim. Together, they contribute to pioneering research that fosters innovation in therapeutic strategies and drug development.

Conclusion

Scott Delach's inventive spirit and commitment to medicine encapsulate a pivotal part of the ongoing battle against cancer and related diseases. His patents not only pave the way for advancing treatment methods but also exemplify the critical role of innovation in healthcare. As an inventor, Delach continues to make a meaningful impact in the realm of medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…